Clinical Trial Update: Clarifying the Optimal Application of SLT Therapy Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the optimal use of selective laser trabeculoplasty (SLT) therapy for glaucoma and ocular hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Snippet

Sponsor: University of Pittsburgh | Conditions: Glaucoma and Ocular Hypertension | Phase 3 | Status: RECRUITING